While some infectious diseases, such as measles, typically confer lifelong immunity after a single natural infection, many others do not. For these diseases, natural infection may only provide temporary protection, and...
The European Vaccines Hub for Pandemic Readiness (EVH) is a newly established, EU-funded public-private partnership led by the Sclavo Vaccines Association (Siena, Italy), pooling 11 major beneficiaries and 13 affiliated...
Clostridiodes difficile infection (CDI) remains a substantial public health issue, despite some recent reductions in healthcare-associated CDI.(1) Antimicrobial resistance is emerging(2), and relapse/recurrence is...
Certain groups are at increased risk for severe disease courses, complications, hospitalization, or death from influenza. The main risk groups include: Older adults: Especially those aged 60 years and above. Young...
Still today, 90% of influenza vaccine doses produced annually are egg-based. They are cheap and have a well-documented excellent safety profile. However, in case of an influenza pandemic with a “bird-flu-strain”, there...
In Asia, major producers are scaling up both legacy and next-generation vaccine capacity. India’s Serum Institute, the world’s largest vaccine manufacturer, recently announced expanded partnerships with African...
1. Epidemiology Seasonal Trends (2024–2025): The most recent data indicates that influenza A activity peaked early in 2025, with overall acute respiratory illness at very low levels in July 2025. Most regions...
Italy to leave IHR and WHO? Shortly before the deadline, the Italian government officially rejected the World Health Organization’s (WHO) amendments to the International Health Regulations (IHR) concerning global...
Epidemiology and trends Adenovirus infections remain a significant cause of respiratory and gastrointestinal illness worldwide, especially in infants, young children, immunocompromised individuals, and those with...
Western vaccine manufacturers Pfizer-BioNTech: Expanded RSV vaccine recommendations for older adults The Centers for Disease Control and Prevention (CDC) updated its guidance to recommend the Pfizer-BioNTech RSV vaccine...